KOICHI TAKAHASHI to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications KOICHI TAKAHASHI has written about Xenograft Model Antitumor Assays.
Connection Strength
0.057
-
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood. 2024 05 16; 143(20):2059-2072.
Score: 0.031
-
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia. J Exp Med. 2021 05 03; 218(5).
Score: 0.025